Reproductive endocrinology

Shared and divergent acute cardiovascular risk protein responses to lipid infusion in women with and without polycystic ovary syndrome (PCOS)

Diabetes Obes MetabPublished Randomised crossover study

Authors' conclusion

Acute lipid infusion revealed shared and phenotype-specific proteomic responses linked to early vascular stress. In PCOS, persistent dysregulation suggests reduced metabolic adaptability, with exploratory signals that may complement established biomarkers of early cardiovascular risk.

Study context

Population
Healthy control women and women with PCOS10 healthy control (HC), 12 PCOS · Healthy control women 10 · women with PCOS 12
Comparison
Intralipid vs saline infusion, in HC women and women with PCOS
Primary endpoint
Plasma CVRP expression (SOMAscan proteomics)
Follow-up
Baseline, post-lipid (180 min) and post-clamp (300 min)
Methodological detailscross-over, hyperinsulinemic-euglycemic clamp, SOMAscan proteomics
  • Cross-over
  • Hyperinsulinemic-euglycemic clamp
  • SOMAscan proteomics

Primary result

As reported in the abstract

CVRP expression after lipid infusion, HC · post-lipid (180 min)
Cardiovascular risk proteins (CVRPs) altered by lipid infusion in HC
11 out of 54
Increased in HC: RANK, IL2RA, TACI, SLAF5, DCN
p <0.05
Decreased in HC: THPO, BOC, SOD2, FGF23, AgRP
p <0.05

Further findings

CVRP responses in PCOS

Responses mirrored HC except lower AgRP following lipid infusion
P < 0.01
Persistent elevation of SLAF5 and DCN following insulin in PCOS
P < 0.05

Enrichment analysis

Altered proteins linked to immune activation, cell proliferation and cytokine-receptor signalling

Original publication

Shared and divergent acute cardiovascular risk protein responses to lipid infusion in women with and without PCOS. Diabetes Obes Metab. Published 29 September 2025. doi:10.1111/dom.70154

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.